Immunodiagnostic Systems Holdings plc
Description
Established in 1977, as a Distributor of diagnostic products, IDS has become a globally-recognised innovator and marketeer in the IVD industry.
The Company is particularly well-known for its expertise in creating tools to aid in the diagnosis of diseases of Bone & Calcium dysfunction (osteoporosis; osteomalacia; Paget's disease), in monitoring response to therapy, and, indeed, in studying the fundamental mechanisms of such bone disorders.
IDS listed on AIM in December 2004
Stock Ticker
IDH
Chairman
David Evans
CEO
Roger Duggan
FD
Paul Hailes
Latest Headlines for Immunodiagnostic Systems Holdings plc
IDS targets Biocode Hycel acquisition Friday, August 03, 2007
IDS profits soar over first halfMonday, November 07, 2005
IDS gets new vitamin D testing kits cleared for useFriday, August 12, 2005
|
Share Data
(15 minutes delayed)
| Latest trade time | 14:50:18 | | Share Price | 139.00 | | Change Today | -3.50 | | % Change Today | -2.46 | | Volume | 1500 | | Today High | 142.50 | | Today Low | 139.00 | | 52 Week High | 291.00 | | 52 Week Low | 135.50 | No. of shares
in issue | 26m | | Market Capitalisation | £36.14m |
This is a solution provided by Digital Look Corporate
Solutions
incorporating their prices and data, on this site.
Terms & Conditions
|
|